Inhibitory effect of C-reactive protein on the release of tissue factor pathway inhibitor from human endothelial cells: Reversal by low molecular weight heparin

International Angiology

Volumn 25, Issue 1, 2006, Pages 10-13

  Mousa, S A ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

C reactive protein; Endothelium; Heparins; Hypercoagulation; Low molecular weight heparin; Thrombosis; Tissue factor pathway inhibitor

Indexed keywords

ANTIGEN; C REACTIVE PROTEIN; FIBRONECTIN; LOW MOLECULAR WEIGHT HEPARIN; POLYMER; TINZAPARIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANTICOAGULATION; ARTICLE; CELL SUSPENSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; MOLECULAR WEIGHT; PROTEIN SECRETION; UMBILICAL VEIN;

ANTICOAGULANTS; C-REACTIVE PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LIPOPROTEINS; UMBILICAL VEINS;

EID: 33645829849     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Folsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 2002;144:233-8.
2. Wang TJ, Larson MG, Levy D, Benjamin EJ, Kupka MJ, Manning WJ et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation 2002;106:1189-91.
3. Venugopal SK, Devaraj S, Jialal I. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens 2005;14:33-7.
4. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-20.
5. Paffen E, Vos HL, Bertina RM. C-reactive protein does not directly induce tissue factor in human monocytes. Arterioscler Thromb Vasc Biol 2004;24:975-81.
6. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004;44:6-11.
7. Ott I, Malcouvier V, Schomig A, Neumann FJ. Proteolysis of tissue factor pathway inhibitor-1 by thrombolysis in acute myocardial infarction. Circulation 2002; 105:279-81.
8. Lindahl AK. Tissue factor pathway inhibitor: a potent inhibitor of in vitro coagulation and in vivo thrombus formation. Curr Opin Lipidol 1994;5:434-9.
9. Alban S. Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulation in plasma. Semin Thromb Hemost 2001;27:503-11.
10. Hansen JB, Sandset PM, Huseby KR, Huseby NE, Bendz B, Ostergaard P et al. Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombic action. Br J Haematol 1998;101:638-46.
11. Bendz B, Hansen JB, Andersen TO, Ostergaard P, Sandset PM. Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins. Br J Haematol 1999; 107:756-62.
12. Bendz B, Andersen TO, Sandset PM. Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins. Blood Coagul Fibrinolysis 2000; 11:343-8.
13. Mousa SA, Kaiser B. Tissue factor pathway inhibitor in thrombosis and beyond: role of heparin. Drugs Future 2004; 29:751-66.
14. Mousa SA, Bozarth J, Barrett JS. Pharmacodynamic properties of the low molecular weight heparin, tinzaparin: effect of molecular weight distribution on plasma tissue factor pathway inhibitor in healthy human subjects. J Clin Pharmacol 2003;43:727-34.
15. Siugh U, Devaraj S, Jalal I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol 2005;25:2216-21.
16. Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999;190:1733-40.
17. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111:1805-12.
18. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-43.